Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eli Lilly

884.54
+24.812.89%
Post-market: 887.402.86+0.32%19:59 EDT
Volume:3.40M
Turnover:2.97B
Market Cap:838.53B
PE:75.54
High:885.58
Open:859.66
Low:851.07
Close:859.73
Loading ...

3 of Goldman Sachs' best investing tips for currently volatile markets

Yahoo Finance
·
21 Mar

Eli Lilly Launches Weight-Loss Drug Mounjaro In India, Beats Novo Nordisk To Major Market

Reuters
·
21 Mar

China's Commerce Minister Met With CEO of Eli Lilly on Friday

THOMSON REUTERS
·
21 Mar

China's Commerce Minister: Hopes Foreign-Funded Enterprises Will Overcome Uncertain Impact of External Environment, Continue to Deepen Business in Chinese Market

THOMSON REUTERS
·
21 Mar

6 'Megacap' Stocks to Buy That Aren't Big Tech -- Barrons.com

Dow Jones
·
21 Mar

FACTBOX-Lilly's weight-loss drug launch in India to energize rivals eyeing mega market

Reuters
·
21 Mar

BUZZ-U.S. STOCKS ON THE MOVE-KKR, Micron Technology, Eli Lilly

Reuters
·
20 Mar

Eli Lilly Shares up 1.7% After Launch of Weight-Loss Drug Mounjaro in India

THOMSON REUTERS
·
20 Mar

MORNING BID AMERICAS-Fed soothes as Trump seethes

Reuters
·
20 Mar

5 Reasons It's Not Too Late to Buy Eli Lilly Stock

Motley Fool
·
20 Mar

BRIEF-Lilly Says Mounjaro 2.5 Mg Vial Priced At 3,500 Rupees In India

Reuters
·
20 Mar

Lilly Says Mounjaro 2.5 Mg Vial Priced at 3,500 Rupees in India

THOMSON REUTERS
·
20 Mar

Eli Lilly launches weight-loss drug Mounjaro in India after drug regulator approval

Reuters
·
20 Mar

Lilly Launches Mounjaro, Offering a New Option for the Treatment of Obesity and Type 2 Diabete- Statement

THOMSON REUTERS
·
20 Mar

Sale of Ozempic Knockoffs Are Supposed to End Soon. Telehealth Companies Aren't Happy. -- WSJ

Dow Jones
·
19 Mar

Novo Nordisk A/S (NVO) Traded Lower Due To Investor Disappointment Over Its New Drug In Obesity

Insider Monkey
·
19 Mar

3 Market-Beating Stocks to Target This Week

StockStory
·
19 Mar

BRIEF-Ampersand Biomedicines Raises Series B Financing

Reuters
·
19 Mar

Ampersand Biomedicines - Series B Funding From Investors Including Ampersand's Founder, Flagship Pioneering, Eli Lilly & Company

THOMSON REUTERS
·
19 Mar

Amgen Rises Almost 22% YTD: Should You Buy, Hold or Sell the Stock?

Zacks
·
18 Mar